Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996236PMC
http://dx.doi.org/10.1097/RHU.0000000000001279DOI Listing

Publication Analysis

Top Keywords

reactive hemophagocytic
4
hemophagocytic lymphohistiocytosis-associated
4
lymphohistiocytosis-associated kikuchi-fujimoto
4
kikuchi-fujimoto disease
4
disease staphylococcus
4
staphylococcus epidermidis
4
epidermidis cutaneous
4
cutaneous infection
4
infection case
4
case report
4

Similar Publications

Cytokine storm syndromes such as hemophagocytic lymphohistiocytosis (HLH), Adult-onset Still's disease (AOSD), and COVID-19 cytokine storm (CCS) are characterized by markedly elevated inflammatory cytokines. However clinical measurement of serum cytokines is not widely available. This study examined the clinical utility of C-reactive protein (CRP) and ferritin, two inexpensive and widely available inflammatory markers, for distinguishing HLH from AOSD and CCS.

View Article and Find Full Text PDF

Unlabelled: We report on a 67-year-old male patient admitted to the Internal Medicine department for fever, joint pain and exertional dyspnoea. Two months before his admission, the patient had been diagnosed with pauci-immune necrotising glomerulonephritis, for which he had been treated with rituximab and corticosteroids. Upon admission the patient was stable, but within a few hours he became unstable as liver failure and acute cytopaenia occurred.

View Article and Find Full Text PDF
Article Synopsis
  • Hemophagocytic syndrome (HPS) is a serious condition that can lead to heart failure, and this study aimed to find out which factors are predictors of developing heart failure in these patients.* -
  • Using CART analysis on 146 HPS patients, researchers discovered that factors like cardiothoracic ratio (CTR), NT-proBNP levels, and C-reactive protein (CRP) are significant predictors, with CTR being the most critical one.* -
  • The results underscore the importance of early identification of these predictors to improve patient outcomes and inform future research on managing heart failure in HPS.*
View Article and Find Full Text PDF

Regorafenib-Triggered Hemophagocytic Lymphohistiocytosis: A Report of Two Cases.

Cureus

October 2024

Department of Medical Oncology, Oncopole Claudius Regaud, Toulouse, FRA.

Hemophagocytic lymphohistiocytosis (HLH) is a rare, potentially fatal condition, characterized by overactivation of the immune system. It can manifest as primary or secondary when triggered by infections, neoplasms, or medications. We report here two cases of regorafenib-induced HLH, one of which was life-threatening.

View Article and Find Full Text PDF
Article Synopsis
  • Hemophagocytic lymphohistiocytosis (HLH) is an immune disorder causing severe inflammation, categorized into primary (familial) and secondary (acquired) types; secondary HLH can occur due to various triggers, including infections like Epstein-Barr virus (EBV).
  • A 12-year-old girl with childhood-onset systemic lupus erythematosus (SLE) developed fever, seizures, and altered mental status, raising concerns for neuropsychiatric SLE or infections, leading to extensive testing and treatment.
  • Diagnosis of HLH was confirmed through blood tests showing abnormal cell counts and bone marrow analysis revealing hemophagocytic activity, along with CSF analysis that identified EBV as the
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!